baber/WOPTO huggingface dataset:
Patent PT-1736177-E (PT)
Title: Method and device for the evaporation of volatile substances
Inventor: CASERTA ANDREA
IPC: A61L9/03
Filed: 2004-03-29
Abstract: The present invention refers to a method and a device to evaporate volatile substances such as aromatic substances and/or insecticides, in which these are evaporated using electrical heating means that heat a wick impregnated with the substance to be evaporated. The invention permits the evaporation of the substance efficiently by optimizing the use of heat energy generated by electrical heating devices. The invention comprises a rotating pipe with at least one opening with a portion of wick inserted in the said pipe and depending on the position of the said pipe relative to the heating means the amount of heat flow transmitted to the wick is regulated and, consequently, the degree of evaporation of the substance.
Patent PT-1708693-E (PT)
Title: Pharmaceutical compositions containing paltinum complexes with secondary xanthates and therapeutic uses thereof
Inventor: SCHILLING GERHARD
IPC: A61K33/243
Filed: 2004-12-10
Abstract: Described are platinum complexes with secondary xanthates and therapeutic uses thereof for treating tumors and autoimmune diseases.
Patent PT-1766401-E (PT)
Title: Method for the simple and rapid detection of cells and biomolecules by means of paramagnetic particles
Inventor: KIESEWETTER HOLGER
IPC: G01N33/543
Filed: 2005-07-12
Abstract: The invention relates to a simple and rapid method for the detection of cells and biomolecules by means of paramagnetic particles (beads) without separating the detected biomolecules or target cells from the beads before evaluating the specific bond.
Patent PT-671947-E (PT)
Inventor: SASTRY JAGANNADHA K
IPC: C07K14/115
Filed: 1992-12-02
Abstract: Use of a composition comprising a peptide of 8 to 24 residues comprising the sequence RAFVTIGK for the preparation of a medicament for the inhibition of HIV.
Patent PT-659083-E (PT)
Inventor: APFEL STUART C
IPC: A61K38/08
Filed: 1993-06-01
Abstract: The invention features a method of using insulin-like growth factor-I (IGF-I) or insulin-like growth factor-III (IGF-III) to prevent or treat peripheral neuropathy in a mammal.
Patent PT-659353-E (PT)
Inventor: NYFFELER URS
IPC: A24C5/00
Filed: 1994-12-22
Abstract: A kit for making a smoking article comprises a hull 10 which itself comprises a hollow cylinder 14 of cigarette paper having a filter at one end joined to it by tipping 16. The kit also includes a rectangular sheet 12 of reconstituted tobacco, the long side of which is the same length as the cylinder. The smoker rolls the sheet into a cylindrical shape and inserts it into the hull to make a cigarette. <IMAGE>
Patent PT-757828-E (PT)
Inventor: KATZ BARRY
IPC: H04N7/08
Filed: 1995-04-24
Abstract: A surveillance system which can store and replay information which is not generated contemporaneously. In some point-of-sale systems, the behavioral events occur before the transaction data is generated. The present system asynchronously records the video signals corresponding to the behavioral events and the transaction data. Upon playback, the transaction data is matched up with the behavioral event being replayed from the video tape.
Patent PT-783333-E (PT)
Inventor: MALTABES ANGELO JOHN
IPC: A61M5/00
Filed: 1995-09-26
Abstract: PCT No. PCT/AU95/00634 Sec. 371 Date May 27, 1997 Sec. 102(e) Date May 27, 1997 PCT Filed Mar. 26, 1995 PCT Pub. No. WO96/09845 PCT Pub. Date Apr. 4, 1996There is provided a burette apparatus having a delivery tube connecting a fluid bag to a burette assembly, via a fluid entry spigot formed in an end cap assembly of the burette assembly, the end cap assembly having a bypass spigot connected to the delivery tube and usually closed by clip, to allow an override for adding liquid to the burette. The end cap assembly closes the upper end of the transparent, cylindrical burette body, into which extends a stainless steel tube extension of the fluid entry spigot, the lower end of the burette body being closed by a lower closure assembly having a check valve and a drip chamber. An outlet tube passes from the drip chamber to the patient via regulating clamp. A float assembly is located in the burette body including an extension rod provided with a resilient cup adapted to engage the open end of the stainless steel tube extension.
Patent PT-837677-E (PT)
Inventor: LEE KUO-HSIUNG
IPC: C07D317/68
Filed: 1996-06-07
Abstract: Disclosed herein are derivatives of 4,4'-dimethoxy-5,6,5'6'-bimethylenedioxy 2,2'-dimethoxycarbonyl biphenyl (DDB) which were synthesized and found to have anti-HIV activity. Of the compounds studied, 3,3'-dibromo DDB and 3-bromo-DDB initially exhibited the greatest anti-HIV activity.
Patent PT-1002168-E (PT)
Inventor: SCHUERMANN WOLFRAM
IPC: E04D13/17
Filed: 1998-08-06
Abstract: The invention relates to a ridge and/or hip ventilation element (10) having a central part (11) which can be fixed onto a ridge lath and/or a hip lath (15), and a side part (12). Both sides of the central part (11) are adjoined by side parts (12), which can be placed by their outer edge areas (26) on roof coverings (20), and are so configured as to let air circulate between their edge areas (26) and the central part (11). The side parts (12) have longitudinal folds (18, 19, 28 to 30) in their air-permeable area (16) and/or in their outer edge areas (26). These longitudinal folds extend in the longitudinal direction (17) of the ridge and/or hip ventilation element and create a storage area. The ridge and/or hip ventilation element (10) is thus so configured as to be extractable by its lateral length. By using this ridge and/or hip ventilation element (10), open spaces of different sizes between the ridge lath and the roof covering can be covered in such a way that air circulation is possible between the ridge lath and the roof covering, and the space between the ridge bricks and the roof covering is easy to seal.
Patent PT-1101115-E (PT)
Inventor: LIHME ALLAN OTTO FOG
IPC: G01N33/531
Filed: 1999-07-29
Abstract: The preparation of a new water-soluble cross-linked conjugates and cross-linked conjugate complexes improves the detection ability of immunochemical assays, including lateral flow devices, and relies on a "salting-out" process in which a reversible precipitate is formed at lyotropic salt concentrations greater than 1 M and coincides with a cross-linking of the backbone of the water-soluble intermediate conjugate. The backbone which consists of polysaccharides, including dextrans, is linked to a signal component, such as a dye, that produces a colour, via a bifunctional linker component, such as epichlorohydrin or divinyl sulfone, and optionally through a protein spacer component such as ovalbumin (OA) or bovine serum albumin (BSA). The cross-linking of the dextrans occurs via the linker component, during the "salting-out" process to give, in the presence of suitable targets such as antibodies or antigens, water-soluble cross-linked conjugates and cross-linked conjugate complexes. <IMAGE>
Patent SG-5688-G (SG)
Title: Button
IPC: A44B1/34
Filed: 1988-01-23
Abstract: A button hs a body (1) and a retainer (2) for securing the body to cloth. The retainer has a T-shaped member (5) with the leg of the T-shaped member (5) remote from the cross piece (6) shaped to form a hollow cup-shaped resiliently expandable member (8), the rim of which is directed toward the cross piece (6). The body has a receptacle formed by a blind bore (11) opening into a cup-shaped cross section similar to that of the resiliently expandable member. In operation the resiliently expandable member (8) rim (9) is contracted and the resiliently expandable member is pushed through the bore (11) into the receptacle cup-shaped cross setion (12) whereupon the resiliently expandable member (8) expands to hold the retainer (2) in locked position with the body (1).
Patent SG-72994-G (SG)
Title: Blade assembly.
Inventor: FERRARO FRANK A
IPC: B26B21/22
Filed: 1994-06-03
Abstract: A blade assembly (10) comprises first and second blades (24) and (24') which are pivotally mounted to the rest of the assembly (10). This enables the span of each blade to be altered in response to the amount of shaving force generated by the user.
Patent IE-38824-L (IE)
Title: Phosphoric acid purifier
IPC: C01B25/46
Filed: 1974-02-04
Abstract: 1464536 Phosphoric acid; phosphates ALBRIGHT & WILSON Ltd 7 Feb 1974 [7 Feb 1973] 6056/73 Heading C1A [Also in Division C2] A process for preparing an anhydrous crystalline compound of phosphoric acid and diisopropyl ether comprises producing a mixture of di-isopropyl ether with phosphoric acid (H 3 PO 4 ) in a molar proportion (R : 1) of 0À6 : 1 to 1À4 : 1 and an amount of water from 0 to 1 mole water/mole of H 3 PO 4 and if the temperature of the mixture is above the crystallization temperature, T C., where T=25 (1À2-R), cooling the mixture to a temperature at least as low as the crystallization temperature and separating crystals of the compound. Aqueous phosphoric acid (65-100% acidity) may be mixed with the ether to produce the above mixture directly as an organic phase with g = 3À3- [1À4(C - 65) - T] where g is the number of grams of ether (expressed as 95% ether, 4% phosphoric acid and 1% water) per 100 g. of aqueous phosphoric acid of acidity C%. The process may be used for the purification of wetprocess phosphoric acid with an acidity of 75-85% to produce pure phosphoric acid or phosphates, by reacting the compound with water, ammonia or an alkali metal or alkaline earth metal oxide, hydroxide, carbonate, bicarbonate, tribasic phosphate or dibasic phosphate.
[GB1464536A]
Patent IE-44878-L (IE)
Title: Implantable cardiac pacer.
IPC: A61N1/372
Filed: 1977-02-08
Abstract: The various operating parameters of this implantable digital pacemaker can be set from outside by means of control signals. The control signals received by a receiver, e.g. magnetic tongue switch, are processed by a pulse generator (151) to form a digital signal, and the latter is processed in a counting device (182) to form a binary signal which denotes the number of the pulses present in the control signal. The binary control signal is not input by the counting device (182) into a memory (184) until the complete control signal has been received by the receiver. The controlling equipment, such as frequency regulator, amplitude regulator, pulse width controller, etc. is connected to the memory (184). Intermediate storage of the control signal in the counting device (182) excludes faulty adjustments as well as undesired short-term intermediate adjustments. <IMAGE>
[GB1577371A]
Patent IE-35142-L (IE)
Title: Milking apparatus
IPC: A01J5/017
Filed: 1971-04-16
Abstract: Means for supporting a teat cup assembly of milking apparatus in a position adjacent a milking stall whereby the teat cup assembly is supported above the floor of the stall and readily accessible to a milker. The support means includes a hinged arm so that the teat cup assembly may be supported at or near the outer end of such arm, and the teat cup assembly is supported in a retractible manner whereby it may immediately retract to a "home" position supported by the arm upon removal of the teat cups from a milked animal and so that the teat cup assembly cannot fall and contact the floor of the stall on removal from the animal. A vacuum supply cut-off device is associated with the retractible support means and the vacuum supply hose for the teat cup assembly to provide an arrangement whereby the vacuum supply to a teat cup assembly fitted to an animal can be cut off to permit the teat cup assembly to fall away from the animal with the result that the retractible support means immediately comes into operation to retract the teat cup assembly to the "home" and supported position without manual effort.
[US3738321A]
Patent IE-850699-L (IE)
Title: A double pump adapted for use as an artificial heart
IPC: A61M60/882
Filed: 1985-03-19
Abstract: A double pump adapted for use as an artificial heart includes two ventricle-simulating chambers that are provided with respective inlets and outlets having valves incorporated therein and that are separated by a common partitioning wall structure. The wall structure has sections that are driven away from each other to reduce the volumes of respective ventricle chambers and expel liquid from the chambers through the outlets. The wall structure can also move laterally in response to differences in pressure between the chambers and hence change the volumetric ratio between them. This ensures a balanced action between the two halves of the heart- simulating pump during a systole phase and a diastole phase. The link mechanism is actuated by a cord through a motor, although only in one direction in the pressure phase, and hence the aforementioned changed volumes are readjusted primarily through the pressure exerted by the inflowing fluid. The pump may also include a variable volume atrium-simulating chamber communicating with the inlet to each ventricle-simulating chamber and having volume that is controlled in part by an externally acting gas pressure that varies in accordance with changes in the volumes of the ventricle chambers.
Patent IE-790739-L (IE)
Title: Disposable product
IPC: A61F13/15
Filed: 1979-08-08
Abstract: The disposable product has an absorbent core (12) comprising a corrugated tissue (20) sandwiched between two separate layers of fluffed pulp (14, 16), upper and lower wadding layers (24, 22), a water impervious sheet (26) provided with a glue line 28 on its edges (30, 32) wrapped about the top wadding layer (24) and the core (12) so as to only partially overlie the lower wadding layer (22), and a sheet of non-woven material (34) wrapped about the assembly and provided with a longitudinal strip or strips of pressure sensitive adhesive (36, 40) covered by a release paper (38). The lower layer (16) of fluffed pulp is embossed and printed to form coated recesses (18) partially therethrough for accommodating and absorbing substantial discharges of material at a rate faster than otherwise possible so as to prevent leakage. The material (19) beneath the recesses is substantially compressed. <IMAGE>
[GB2017505A]
Patent IE-32185-L (IE)
Title: Fixing device
IPC: F16B13/06
Filed: 1968-07-02
Abstract: 1,227,535. Anchor bolts. P. L. LUNN, and D. FARNWORTH. 14 June, 1968 [31 Aug., 1967], No. 39775/67 Heading F2H. An anchor bolt assembly for securing an article 29 to a structure 30 comprises a bolt 20 on which is mounted a non-metallic permanently deformable sleeve 24, the sleeve 24 being so compressed axially of the bolt 20 when the bolt is located in coaxial bores in the article 29 and structure 30 that it radially distorts to grip firmly the wall of the bore in the structure thereby to secure the bolt to the structure 30. The sleeve 24 is compressed between a peripheral shoulder on the bolt head 22 and a metal sleeve 25 which surrounds the bolt shank and which may form part of or be separate from a nut 26a threaded on the bolt 20. More than one deformable sleeve 24 may be provided and the or each sleeve 24 may be of polyvinylchloride or like plastics material. The nut, in the case where it is integral with the metal sleeve, may be provided with a slotted, conical or hemispherical end (Figs. 8 to 11, not shown) and a loose sleeve (50) may be additionally provided between the nut and the deformable sleeve.
[GB1227535A]
Patent IE-790980-L (IE)
Title: Comminution of solid crystalline material
IPC: B02C23/06
Filed: 1979-08-08
Abstract: A process is described for the comminution of a solid material in the presence of a saturated solution of the solid in a liquid in which the solid has a solubility greater than 1%, and also in the presence of an additive dissolved in the saturated solution which can at least partially inhibit regrowth at crystal surfaces of the solid material. The process is of particular interest for the comminution of water-soluble salts in the presence of their saturated aqueous solutions and may be employed to make, inter alia, improved slurry explosives and fluid fertiliser compositions.
[EP0006294A1]
Patent FI-830360-L (FI)
Inventor: HORROBIN DAVID FREDERICK
IPC: A61K45/06
Filed: 1983-02-02
Abstract: Topical pharmaceutical compositions for the treatment of lesions of the skin or mucous membranes containing a physiologically acceptable lithium salt together with at least one substance selected from substances capable of selectively increasing the in vivo level of E-series prostaglandins, substances capable of inhibiting cyclooxygenase enzyme, substances capable of inhibiting the formation of lipoxygenase products, and lysine.
Patent FI-853586-L (FI)
Inventor: AGBACK KARL HUBERT
IPC: C07C235/84
Filed: 1985-09-18
Abstract: A compound having a potentially inhibitory effect on 15-hydroxy-prostaglandin dehydrognase (PGDH) and having the formulain whichR<sub>1</sub> and R<sub>2</sub> are hydrogen or lower alkyl;R<sub>3</sub> is hydrogen, lower alkyl or substituted or unsubstituted phenyl;R<sub>4</sub>, R<sub>5</sub> and R<sub>e</sub> are hydrogen, halogen, lower alkyl, lower alkoxy, cyano, carboxy or nitro; at least one of the groups R<sub>4</sub> to R<sub>6</sub> being hydrogen;R<sub>7</sub> to R<sub>11</sub> are hydrogen, halogen, cyano, lower alkyl, trifluoromethyl, lower alkoxy, hydroxy, lower acyl, lower alkoxycarbonyl, N,N,-diloweralkyl-aminocarbonyl or N,N-loweralkylene-aminocarbonyl; and R<sub>8</sub> to R<sub>10</sub> may in addition be carboxy; at least two of R<sub>7 </sub>to R<sub>11</sub> always being hydrogen; and -A- is -CO-, -CH<sub>2</sub>-CO-, -CH=CH-, -CH=CH-<sub>CO</sub>- or corresponding groups in which a hydrogen atom is replaced by a lower alkyl group.The invention comprises also lactones of those compounds in which R<sub>1</sub> is hydrogen, and salts of those compounds which contain at least one carboxy group.
Patent IE-781008-L (IE)
Title: Capsule body
IPC: C03B23/18
Filed: 1978-05-19
Abstract: Capsule body, in particular for use with a joined capsule for a pharmaceutical preparation, and method of and apparatus for producing it.
[US4247006A]
Patent IE-821036-L (IE)
Title: Composite metallization for semiconductor devices
IPC: H01L21/3205
Filed: 1982-05-03
Abstract: Lower contact and interconnect metallization series resistance on semiconductor devices is achieved while avoiding the material and process incompatibility problems of the prior art by utilizing a composite metallization (42, 44, 49) structure employing two superposed intermetallic layers (44, 49) of different properties. The first intermetallic (44) is chosen for high conductivity and compatibility with the device interfaces. The second intermetallic (49) functions as a conductive protective "cap" and is chosen for conductivity and compatibility with subsequent process steps. The two intermetallics (44, 49) must also be compatible. For silicon devices the preferred first and second intermetallics are respectively, silicon rich titanium silicide and titanium nitride, but other materials are also useful. Polycrystalline silicon (42) is desirable for a base layer under the first intermetallic (44) in certain device structures such as MOS gates. The composite metallization is prepared by a lift-off technique.
[WO8203948A1]
Patent IE-851192-L (IE)
Title: (r)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide
IPC: C07D207/27
Filed: 1985-05-14
Abstract: (R)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide, its preparation and pharmaceutical compositions containing the same. It can be prepared either by reacting (R)-alpha-ethyl-2-oxo-1-pyrrolidineacetic acid successively with an alkyl haloformate and with ammonia, or, by cyclizing an (R)-2-amino-butanamide of the formula X-CH2CH2-Y-NHCH(C2H5)CONH2 wherein Y is a -CH2- radical when X represents a ZOOC- radical and Y is a -CO- radical when X represents a HalCH2- radical, Z being a C1-C4 alkyl radical and Hal a halogen atom. This dextrorotatory enantiomer has been found to have significantly higher mnemic activity and lower toxicity than the corresponding racemate.
[US4696942A]
Patent IE-33850-L (IE)
Title: Pyridoindole derivatives.
IPC: C07D213/42
Filed: 1969-09-09
Abstract: 1,253,742. 2H - Pyrido[4,3-b]indole derivatives. F. HOFFMANN-LA ROCHE & CO. A.G. 10 Sept., 1969 [10 Sept., 1968], No. 44587/69. Heading C2C. The invention comprises compounds of formula wherein R 1 is H, Me, PhCO or Ph-alkyl; R 2 , R 3 , R 4 and R 5 are each H, halogen, alkyl, alkoxycarbonyl, CO 2 H, alkoxy, HOCH 2 or CF 3 ; and R 6 is H or alkyl, each alkyl group therein containing 1-6 C atoms; their pharmaceutically acceptable acid addition salts, and hydrates of such salts. These compounds (excepting those containing CO 2 H or HOCH 2 ) are prepared by reacting an N-amino-N-2-(R 6 -substituted-4-pyridyl)ethylaniline with an N-R 1 -4-piperidone; the CO 2 H-compounds (I) are prepared by hydrolysis of the alkoxycarbonyl-compounds (II), and the HOCH 2 -compounds by reduction of I or II. Starting materials.-The preparation of N-2- (4-pyridyl)ethylaniline and its N-nitroso and N- amino derivatives is described. Therapeutic compositions for oral or parenteral administration comprise compounds of the above formula, which have analgesic activity.
[GB1253742A]
Patent IE-36970-L (IE)
Title: Multicore coaxial pair cable
IPC: H01B13/26
Filed: 1972-11-08
Abstract: 1406998 Coaxial pair cable PIRELLI GENERAL CABLE WORKS Ltd 1 Nov 1972 A multicore coaxial pair cable is made by stranding together coaxial pairs 1 and applying a layer 3 of impact absorbing cellular material around the stranded pairs. Paper tapes 6, 7 may be wound over the impact absorbing material and further concentric layers of coaxial pairs may be applied to the stranded pairs each layer being separated by a layer of impact absorbing material. The material prevents cyclic deformation and the attendant resonance distortions in the coaxial pairs.
[GB1406998A]
Patent IE-811626-L (IE)
Title: Anthracycline glycosides
IPC: C07F5/02
Filed: 1981-07-17
Abstract: The invention relates to compounds of the formula <IMAGE> I wherein R is lower alkyl or a carboxy group or a group of the formula -(CH2)n-OY a in which n stands for 1 or 2 and Y is hydrogen or alkyl and RY and Rz each are hydrogen or one of RY and Rz is hydrogen and the other is hydroxy, and pharmaceutically acceptable acid addition salts thereof. These compounds and salts possess antibiotic and antitumor activity and can be used as medicaments in the form of pharmaceutical preparations.
[US4591636A]
Patent IE-38484-L (IE)
Title: High speed memory subsystem
IPC: G06F13/18
Filed: 1973-10-10
Abstract: 1442167 Data processing systems DIGITAL EQUIPMENT CORP 10 Oct 1973 [10 Oct 1972] 47349/73 Heading G4A A data processing system includes a central processor, a fast access memory, and one or more peripherals, connected in parallel to a bus. The memory is additionally connected direct to the processor. The bus (bus I) comprises 2-way data lines 1A, address lines 1B, and control lines 1C, all connected to a receiver and driver unit 24, necessary because the bus may be long. Data received on lines 1A is passed to data multiplexer 28 which also receives data from a portion 10A of a dedicated bus 10 connected direct to the processor. A synchronizing and timing unit 21 receives control signals from bus 1 and bus 10, and controls unit 28 via line 34 to pass data from input lines 10A or 30 to the memory 20. Address signals on dedicated but lines 10C and from unit 24 pass to an address unit 23 and also to unit 25. This unit indicates to unit 23 whether or not the present address lies within memory 20 and to what section of the memory it relates. The synchronizing unit 21 controls whether a bus 1 address, a bus 10 address, or a refresh address is placed in the address register in unit 23 in accordance with a priority determined by the processor. The accepted address is accessed via lines 27. Periodically the memory is refreshed, the address to be refreshed being selected by unit 22.
[GB1442167A]